Deferiprone: differenze tra le versioni

Contenuto cancellato Contenuto aggiunto
corr.
ins. voci template
Riga 1:
{{Disclaimer medico}}
{{Farmaco
| nome_IUPAC =3-idrossi-1,2-dimetilpiridin-4(1''H'')-one
| immagine = Deferiprone.svg
| dimensione_immagine = 150px
| immagine2 =
| dimensione_immagine2 =
| numero_CAS = 30652-11-0
| prefisso_ATC =V03
| suffisso_ATC =AC02
| PubChem =2972
| DrugBank =
| formula =C=7|H=9|N=1|O=2
| massa_molecolare =139.152 g/mol
| smiles =O=C\1C(\O)=C(/N(/C=C/1)C)C
| sinonimi =
| densità =
Riga 30:
| fascia =
| dispensazione =
| somministrazione = orale
}}
 
Riga 44:
 
Sono stati pubblicati a tutto giugno 2010 più di 650 lavori che parlano di deferiprone; tra essi vi sono 4 [[Metanalisi]] rilevanti:
* ''Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation'' <ref name="pmid19068191">{{cite journal | author = McLeod C, Fleeman N, Kirkham J, ''et al.'' | title = Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation | journal = Health Technology Assessment (Winchester, England) | volume = 13 | issue = 1 | pages = iii–iv, ix–xi, 1–121 | year = 2009 | month = January | pmid = 19068191 | doi = 10.3310/hta13010 | url = http://www.hta.ac.uk/execsumm/summ1301.htm | issn = | accessdate = 2010-07-09}}</ref>*
* ''Oral deferiprone for iron chelation in people with thalassaemia'' <ref name="pmid17636775">{{cite journal | author = Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ | title = Oral deferiprone for iron chelation in people with thalassaemia | journal = Cochrane Database of Systematic Reviews (Online) | volume = | issue = 3 | pages = CD004839 | year = 2007 | pmid = 17636775 | doi = 10.1002/14651858.CD004839.pub2 | url = http://dx.doi.org/10.1002/14651858.CD004839.pub2 | issn = | accessdate = 2010-07-09}}</ref>
* ''Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia'' <ref name="pmid16235363">{{cite journal | author = Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S | title = Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia | journal = Cochrane Database of Systematic Reviews (Online) | volume = | issue = 4 | pages = CD004450 | year = 2005 | pmid = 16235363 | doi = 10.1002/14651858.CD004450.pub2 | url = http://dx.doi.org/10.1002/14651858.CD004450.pub2 | issn = | accessdate = 2010-07-09}}</ref>